Biofrontera stock climbs as drug-device succeeds in Phase III skin cancer trial
Biofrontera has announced topline results from a Phase III trial evaluating its drug-device therapy, Ameluz gel and photodynamic therapy (PDT)…
Oncology
-
-
GE unveils genAI CareIntellect oncology data aggregator platform
GE Healthcare has unveiled a new generative AI (genAI) platform, CareIntellect for Oncology, which will be available for commercial use…
-
Aspira Women’s Health gets approval for OvaWatch ovarian cancer test
Aspira Women's Health has received approval from the New York State Department of Health's (NYDOH) Clinical Laboratory Evaluation Program (CLEP)…
-
ICR researchers study saliva-based test for prostate cancer
Researchers at the Institute of Cancer Research in London have launched a study to evaluate a new saliva-based test, PRODICT,…
-
SkylineDx reports data from melanoma genomic assay in US trial
SkylineDx, a biotech company, has announced new findings from the MERLIN_001 clinical trial of melanoma genomic assay, Merlin test, in…
-
PROCEPT BioRobotics wins FDA IDE for aquablation trial in prostate cancer
The US Food and Drug Administration (FDA) has awarded PROCEPT BioRobotics an investigational device exemption (IDE), greenlighting a pivotal trial…
-
Perimeter completes enrolment for AI-assisted breast imaging trial
Perimeter Medical Imaging AI has completed enrolment for the pivotal trial of its AI-assisted imaging technology, the Perimeter B-Series OCT…
-
Argon Medical introduces Intara Introducer Sheath and TLAB system
Argon Medical Devices has announced the expansion of its liver management portfolio with the introduction of the Intara Introducer sheath…
-
FDA approves study of Alpha Tau’s Alpha DaRT for recurrent cSCC treatment
The US Food and Drug Administration (FDA) has granted approval for Alpha Tau Medical’s investigational device exemption (IDE) application to…
-
ESMO 2024: Natera showcases chemotherapy prediction benefit of cDNA test
Natera has released new data from the GALAXY arm of its ongoing CIRCULATE-Japan trial showing the efficacy of its molecular…
